Could cause temporary or reversible harm; serious harm is unlikely.
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
| Brand name | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Generic name | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Active ingredient(s) | HYDROCHLOROTHIAZIDE, LISINOPRIL |
| Distributed by / for | Lupin Pharmaceuticals Inc. |
| NDC | 68180-519-01 |
| Full product label | Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Product was distributed nationwide within the United States. |
| Quantity | 58,968 bottles |
| Recall initiated | 2025-06-20 |
| Report date | 2025-07-23 |
| Recall completed | — |
| Recall number | D-0532-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Naples FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗